Clinical Questions in Cardiology: Using Glucagon-like Peptide-1 Receptor Agonists cover art

Clinical Questions in Cardiology: Using Glucagon-like Peptide-1 Receptor Agonists

Clinical Questions in Cardiology: Using Glucagon-like Peptide-1 Receptor Agonists

By: Annenberg Center for Health Sciences
Listen for free

About this listen

 In this activity, case studies commonly encountered in cardiology practice are utilized to prompt reflection on opportunities for reducing cardiovascular risk. Drawing on seminal research and their own experience, cardiologist Jorge Plutzy, MD, and endocrinologist Helena Rodbard, MD, navigate through a series of ‘clinical questions’ to inform regarding the clinical pharmacology of the GLP-1RAs and their evidence-based role in cardiovascular risk reduction, particularly in patients with secondary atherosclerotic cardiovascular disease.Annenberg Center for Health Sciences Hygiene & Healthy Living Physical Illness & Disease
activate_mytile_page_redirect_t1
Episodes
  • Cardiologist Collaboration

    Cardiologist Collaboration
    Mar 5 2024
    • Role in Diabetes Management
    • Multidisciplinary Team-based Approach
    Show More Show Less
    5 mins
  • Individualizing Therapy

    Individualizing Therapy
    Mar 5 2024
    • Drug Initiation and Monitoring
    • Contraindications and Adverse Effects
    • Patient Education
    Show More Show Less
    8 mins
  • Cardiovascular Benefits

    Cardiovascular Benefits
    Mar 5 2024
    • FDA Indications
    • Clinical Trial Evidence
    Show More Show Less
    4 mins

What listeners say about Clinical Questions in Cardiology: Using Glucagon-like Peptide-1 Receptor Agonists

Average Customer Ratings

Reviews - Please select the tabs below to change the source of reviews.

Audible.com.au reviews

Amazon Reviews
No Reviews are Available
In the spirit of reconciliation, Audible acknowledges the Traditional Custodians of country throughout Australia and their connections to land, sea and community. We pay our respect to their elders past and present and extend that respect to all Aboriginal and Torres Strait Islander peoples today.